Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review
- PMID: 36825922
- DOI: 10.1111/jvh.13821
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review
Abstract
Hepatitis A (HA) is a vaccine-preventable liver disease with >170 million new cases occurring yearly. In recent outbreaks in the USA, hospitalization and case-fatality ratios were >60% and ~1%, respectively. In Europe, endemicity persists and outbreaks continue to occur. We performed a systematic literature review to understand the changes in HA occurrence in Europe over the past two decades. PubMed and Embase were systematically searched for peer-reviewed articles published between 1 January 2001 and 14 April 2021 using terms covering HA, 11 selected European countries, outbreaks, outcomes and HA virus circulation. Here, we focus on HA occurrence and outbreaks in the five countries with the largest population and the most comprehensive vaccination recommendations: France, Germany, Italy, Spain and the UK; 118 reports included data for these five European countries. Notification rates (≤9.7/100,000 population) and percentages of men among cases (≤83.0%) peaked in 2017. The number of person-to-person-transmitted cases and outbreaks decreased in children but increased in other risk groups, such as men who have sex with men (MSM). Sexually transmitted outbreaks in MSM clustered around 2017. Travel-related outbreaks were few; the proportion of travel-related cases decreased during the past two decades, while the number of domestic cases increased. Despite the existing risk-based vaccination recommendations, HA transmission shifted in proportions from travelers and children to other risk groups, such as MSM and older age groups. Because a substantial proportion of the European population is susceptible to HA, adherence to existing recommendations should be monitored more closely, and enhanced vaccination strategies should be considered.
Keywords: food; men who have sex with men; travel; vaccine.
© 2023 GlaxoSmithKline Biologicals S.A. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
References
REFERENCES
-
- World Health Organization (WHO). WHO immunological basis for immunization series: module 18: hepatitis A. World Health Organization; 2019:58 https://apps.who.int/iris/handle/10665/326501 [Accessed February 14, 2023].
-
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease Study 2016. Lancet. 2017;390(10100):1211-1259.
-
- Centers for Disease Control and Prevention (CDC). Widespread person-to-person outbreaks of hepatitis A across the United States. https://www.cdc.gov/hepatitis/outbreaks/2017March-HepatitisA.htm [Accessed October 29, 2021].
-
- Foster MA, Hofmeister MG, Kupronis BA, et al. Increase in hepatitis A virus infections - United States, 2013-2018. MMWR Morb Mortal Wkly Rep. 2019;68(18):413-415.
-
- Lesmanawati DAS, Adam DC, Hooshmand E, Moa A, Kunasekaran MP, MacIntyre CR. The global epidemiology of Hepatitis A outbreaks 2016-2018 and the utility of EpiWATCH as a rapid epidemic intelligence service. Global Biosecurity. 2021;3(1). doi:10.31646/gbio.100
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous